{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:21:48Z","timestamp":1773876108176,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cbi.2019.01.029","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T16:31:29Z","timestamp":1548693089000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Dimethylfumarate ameliorates hepatic injury and fibrosis induced by carbon tetrachloride"],"prefix":"10.1016","volume":"302","author":[{"given":"Mohamed E.","family":"Mostafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem A.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.01.029_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/HMER.S9051","article-title":"Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies","volume":"3","author":"Ismail","year":"2011","journal-title":"Hepatic Med. Evid. Res."},{"key":"10.1016\/j.cbi.2019.01.029_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.pharmtox.45.120403.095906","article-title":"Hepatic fibrosis: molecular mechanisms and drug targets","volume":"45","author":"Lotersztajn","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.cbi.2019.01.029_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/cmi.2011.53","article-title":"Liver fibrosis: mechanisms of immune-mediated liver injury","volume":"9","author":"Xu","year":"2012","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"10.1016\/j.cbi.2019.01.029_bib4","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.cbi.2019.01.029_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000374096","article-title":"Pathophysiology of liver fibrosis","volume":"33","author":"Pinzani","year":"2015","journal-title":"Dig. Dis."},{"issue":"2","key":"10.1016\/j.cbi.2019.01.029_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cbi.2019.01.029_bib7","first-page":"69","article-title":"Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell","volume":"8","author":"Gabele","year":"2003","journal-title":"Front. Biosci."},{"issue":"8","key":"10.1016\/j.cbi.2019.01.029_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104323","article-title":"Activation of nuclear factor kappa B in the hepatic stellate cells of mice with schistosomiasis japonica","volume":"9","author":"He","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.01.029_bib9","first-page":"361","article-title":"Molecular pathogenesis of liver fibrosis","volume":"120","author":"Brenner","year":"2009","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"issue":"s3","key":"10.1016\/j.cbi.2019.01.029_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1746.2006.04584.x","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"Kisseleva","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.cbi.2019.01.029_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3904\/kjim.2016.268","article-title":"Reversal of liver cirrhosis: current evidence and expectations","volume":"32","author":"Jung","year":"2017","journal-title":"Kor. J. Intern. Med."},{"issue":"20","key":"10.1016\/j.cbi.2019.01.029_bib12","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2019.01.029_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2019.01.029_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/clpt.2012.110","article-title":"Nrf2: a potential target for new therapeutics in liver disease","volume":"92","author":"Bataille","year":"2012","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.cbi.2019.01.029_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0098-2997(00)00004-2","article-title":"Pathogenesis of liver fibrosis: role of oxidative stress","volume":"21","author":"Poli","year":"2000","journal-title":"Mol. Aspect. Med."},{"issue":"2","key":"10.1016\/j.cbi.2019.01.029_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.abb.2007.04.016","article-title":"NOX in liver fibrosis","volume":"462","author":"De Minicis","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.cbi.2019.01.029_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40265-017-0854-6","article-title":"Dimethyl fumarate: a review in moderate to severe plaque psoriasis","volume":"78","author":"Blair","year":"2018","journal-title":"Drugs"},{"issue":"17","key":"10.1016\/j.cbi.2019.01.029_bib18","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1073\/pnas.1603907113","article-title":"Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2","volume":"113","author":"Schulze-Topphoff","year":"2016","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.cbi.2019.01.029_bib19","series-title":"Involvement of HCAR2-Triggered Pathways in Dimethyl Fumarate Effect on Immune and Other Cells","year":"2016"},{"issue":"5","key":"10.1016\/j.cbi.2019.01.029_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0014-4800(66)90023-2","article-title":"Quantitative estimation of peroxidative degeneration of rat liver microsomal and mitochondrial lipids after carbon tetrachloride poisoning","volume":"5","author":"Recknagel","year":"1966","journal-title":"Exp. Mol. Pathol."},{"issue":"10","key":"10.1016\/j.cbi.2019.01.029_bib21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.7150\/ijbs.15154","article-title":"Deficiency of DJ-1 ameliorates liver fibrosis through inhibition of hepatic ROS production and inflammation","volume":"12","author":"Yu","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.cbi.2019.01.029_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.cbi.2019.01.029_bib23","series-title":"Hepatoprotective Effect of Virgoliv Syrup against Ccl4 Induced Hepatic Injury in Rats","first-page":"6","author":"Ingawale","year":"2015"},{"issue":"2","key":"10.1016\/j.cbi.2019.01.029_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10787-017-0329-0","article-title":"Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis","volume":"26","author":"Fran\u00e7a","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.cbi.2019.01.029_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0014-5793(01)02656-4","volume":"502","author":"Dooley","year":"2001","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.cbi.2019.01.029_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.apjtm.2016.01.023","article-title":"Effect of dimethyl fumarate on rats with chronic pancreatitis","volume":"9","author":"Zhang","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"6","key":"10.1016\/j.cbi.2019.01.029_bib27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cbi.2019.01.029_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"10.1016\/j.cbi.2019.01.029_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"issue":"2","key":"10.1016\/j.cbi.2019.01.029_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(00)80079-3","article-title":"Basement membrane peptides as markers of liver disease in chronic hepatitis C","volume":"32","author":"Walsh","year":"2000","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.cbi.2019.01.029_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ar.22694","article-title":"Codistribution of collagen type IV and laminin in liver fibrosis of elderly cadavers: immunohistochemical marker of perisinusoidal basement membrane formation","volume":"296","author":"Mak","year":"2013","journal-title":"Anat. Rec."},{"issue":"8","key":"10.1016\/j.cbi.2019.01.029_bib32","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/ar.23567","article-title":"Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease","volume":"300","author":"Mak","year":"2017","journal-title":"Anat. Rec."},{"issue":"2","key":"10.1016\/j.cbi.2019.01.029_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver\u2014linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cbi.2019.01.029_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jid.2017.08.024","article-title":"Therapeutic targeting of TAZ and YAP by dimethyl fumarate in systemic sclerosis fibrosis","volume":"138","author":"Toyama","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.cbi.2019.01.029_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045870","article-title":"Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta\/Smad signaling","volume":"7","author":"Oh","year":"2012","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.cbi.2019.01.029_bib36","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.3748\/wjg.v23.i25.4508","article-title":"Treatment with dimethyl fumarate ameliorates liver ischemia\/reperfusion injury","volume":"23","author":"Takasu","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cbi.2019.01.029_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.apjtm.2016.01.023","article-title":"Effect of dimethyl fumarate on rats with chronic pancreatitis","volume":"9","author":"Zhang","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.cbi.2019.01.029_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/597134","article-title":"The dual role of Nrf2 in nonalcoholic fatty liver disease: regulation of antioxidant defenses and hepatic lipid metabolism","author":"Chambel","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.cbi.2019.01.029_bib39","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/TP.0000000000000647","article-title":"Treatment with dimethyl fumarate attenuates calcineurin inhibitor-induced nephrotoxicity","volume":"99","author":"Takasu","year":"2015","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cbi.2019.01.029_bib40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1\u2013Nrf2\u2013ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"11","key":"10.1016\/j.cbi.2019.01.029_bib41","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/ars.2010.3211","article-title":"Regulation of the Nrf2\u2013Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases","volume":"13","author":"Villeneuve","year":"2010","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.cbi.2019.01.029_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1615\/CritRevImmunol.2013007247","article-title":"Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy","volume":"33","author":"Gill","year":"2013","journal-title":"Crit. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cbi.2019.01.029_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120254","article-title":"Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro","volume":"10","author":"Brennan","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cbi.2019.01.029_bib44","first-page":"153","article-title":"Antioxidant and anti-inflammatory effects of dimethyl fumarate in hypercholesterolemic rabbits","volume":"4","author":"Nour","year":"2017","journal-title":"Egypt. J. Basic Appl. Sci."},{"issue":"25","key":"10.1016\/j.cbi.2019.01.029_bib45","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.3748\/wjg.v23.i25.4508","article-title":"Treatment with dimethyl fumarate ameliorates liver ischemia\/reperfusion injury","volume":"23","author":"Takasu","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.cbi.2019.01.029_bib46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12975-016-0496-0","article-title":"Dimethyl fumarate and monomethyl fumarate promote post-ischemic recovery in mice","volume":"7","author":"Yao","year":"2016","journal-title":"Transl. Stroke Res."},{"issue":"1","key":"10.1016\/j.cbi.2019.01.029_bib47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-7-30","article-title":"Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1\u03b2, TNF-\u03b1 and IL-6 in an in-vitro model of brain inflammation","volume":"7","author":"Wilms","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.cbi.2019.01.029_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10753-017-0689-z","article-title":"Dimethyl fumarate modulates oxidative stress and inflammation in organs after sepsis in rats","volume":"41","author":"Della Giustina","year":"2018","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.cbi.2019.01.029_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gut.21.1.63","article-title":"Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin","volume":"21","author":"Hahn","year":"1980","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cbi.2019.01.029_bib50","first-page":"114","article-title":"Type IV collagen as marker of fibrosis in nonalcoholic liver disease","volume":"29","author":"Alvina","year":"2016","journal-title":"Universa Medicina"},{"issue":"3","key":"10.1016\/j.cbi.2019.01.029_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF02934493","article-title":"Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables","volume":"32","author":"Takamatsu","year":"1997","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.cbi.2019.01.029_bib52","doi-asserted-by":"crossref","first-page":"G1059","DOI":"10.1152\/ajpgi.1999.276.4.G1059","article-title":"TGF-\u03b21 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis","volume":"276","author":"Kanzler","year":"1999","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.cbi.2019.01.029_bib53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1742-7843.2005.pto_06.x","article-title":"Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid","volume":"96","author":"Muriel","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"41","key":"10.1016\/j.cbi.2019.01.029_bib54","first-page":"1312","article-title":"Less reversal of liver fibrosis after prolonged carbon tetrachloride injection","volume":"48","author":"Lee","year":"2001","journal-title":"Hepato-Gastroenterol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718315047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718315047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:52:27Z","timestamp":1757857947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718315047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":54,"alternative-id":["S0009279718315047"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.01.029","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dimethylfumarate ameliorates hepatic injury and fibrosis induced by carbon tetrachloride","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}